SEC Filing Update: #NKTR Nektar Therapeutics : $73.02

Sector: Healthcare | YTD: 🔼+ 68.21% The SEC disclosed Today (14-AUG-2026) that BIOTECHNOLOGY VALUE FUND L P has DECREASED #NKTR Shares by -17.87% 🔴 * Previous Holdings: 1.52M Shares * Current Holdings: 1.25M Shares * Decrease -272.33K * Decreased (%)-17.87% * Ownership: 3.7% https://www.thinksabio.com/reports/isr/NKTR Institutional ownership in #NKTR has been steadily rising over the past 4 quarters in Shares: Q2 2025: 7.68M Q3 2025: 14.41M Q4 2025: 17.32M Q1 2026: 26.70M The quarterly average prices of #NKTR: Q3 2025: $33.11 Q4 2025: $56.15 Q1 2026: $56.93 📌 Institutional activity in the last 30 days for #NKTR: • BLACKROCK INC – Increased holdings by 1,951,146 shares (29-JUL-2026) • Vanguard Capital Management – Increased holdings by 550,598 shares (31-JUL-2026)